An organoselenium compound improves behavioral, endocrinal and neurochemical changes induced by corticosterone in mice

[1]  H. Onoe,et al.  Metabotropic glutamate 2/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice , 2013, Neuropharmacology.

[2]  A. Serretti,et al.  Newer antidepressants and panic disorder: a meta-analysis , 2013, International clinical psychopharmacology.

[3]  JaneR . Taylor,et al.  Persistent effects of prior chronic exposure to corticosterone on reward-related learning and motivation in rodents , 2013, Psychopharmacology.

[4]  JaneR . Taylor,et al.  Action control is mediated by prefrontal BDNF and glucocorticoid receptor binding , 2012, Proceedings of the National Academy of Sciences.

[5]  E. Seifritz,et al.  Stress-related depression: Neuroendocrine, genetic, and therapeutical aspects , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[6]  E. A. Wilhelm,et al.  Hyperthermic seizures enhance responsiveness to pentylenetetrazole and induce cognitive dysfunction: protective effect of 3-alkynyl selenophene. , 2012, Life sciences.

[7]  Bruce S. McEwen,et al.  Adverse childhood experiences, allostasis, allostatic load, and age-related disease , 2012, Physiology & Behavior.

[8]  R. Hen,et al.  Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety. , 2012, The international journal of neuropsychopharmacology.

[9]  E. R. Kloet,et al.  Mineralocorticoid and glucocorticoid receptors at the neuronal membrane, regulators of nongenomic corticosteroid signalling , 2012, Molecular and Cellular Endocrinology.

[10]  E. A. Wilhelm,et al.  Involvement of GABAergic and glutamatergic systems in the anticonvulsant activity of 3-alkynyl selenophene in 21 day-old rats , 2012, Molecular and Cellular Biochemistry.

[11]  G. Zeni,et al.  Synthesis and antidepressant-like activity of selenophenes obtained via iron(III)-PhSeSePh-mediated cyclization of Z-selenoenynes. , 2012, Organic & biomolecular chemistry.

[12]  JaneR . Taylor,et al.  Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice , 2012, Psychopharmacology.

[13]  JaneR . Taylor,et al.  Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice , 2011, Psychopharmacology.

[14]  J. Rocha,et al.  Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds , 2011, Archives of Toxicology.

[15]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[16]  M. Prigol,et al.  Antidepressant-like pharmacological profile of 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene: Involvement of serotonergic system , 2010, Neuropharmacology.

[17]  Nanxin Li,et al.  mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists , 2010, Science.

[18]  E. Mocaer,et al.  Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways , 2010, BMC Neuroscience.

[19]  K. Behar,et al.  Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole , 2010, Molecular Psychiatry.

[20]  M. Drew,et al.  Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression , 2009, Neuron.

[21]  E. Alleva,et al.  Early life stress as a risk factor for mental health: Role of neurotrophins from rodents to non-human primates , 2009, Neuroscience & Biobehavioral Reviews.

[22]  JaneR . Taylor,et al.  Corticosterone Regulates pERK1/2 Map Kinase in a Chronic Depression Model , 2008, Annals of the New York Academy of Sciences.

[23]  JaneR . Taylor,et al.  Acute Hippocampal Brain-Derived Neurotrophic Factor Restores Motivational and Forced Swim Performance After Corticosterone , 2008, Biological Psychiatry.

[24]  Diego Alves,et al.  Copper iodide-catalyzed cyclization of (Z)-chalcogenoenynes. , 2008, Organic letters.

[25]  Stafford L. Lightman,et al.  The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.

[26]  Marian Joëls,et al.  Corticosteroid hormones in the central stress response: Quick-and-slow , 2008, Frontiers in Neuroendocrinology.

[27]  F. Murray,et al.  Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. , 2008, European journal of pharmacology.

[28]  JaneR . Taylor,et al.  Regionally Specific Regulation of ERK MAP Kinase in a Model of Antidepressant-Sensitive Chronic Depression , 2008, Biological Psychiatry.

[29]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[30]  F. F. Rocha,et al.  Antidepressant-like effect of Cecropia glazioui Sneth and its constituents - in vivo and in vitro characterization of the underlying mechanism. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[31]  F. Holsboer,et al.  Changes in the Hypothalamic-Pituitary-Adrenal Axis and Leptin Levels during Antidepressant Treatment , 2007, Neuropsychobiology.

[32]  J. Fadel,et al.  Acute stress‐mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment , 2007, The European journal of neuroscience.

[33]  L. Kong,et al.  Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. , 2006, Biological & pharmaceutical bulletin.

[34]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[35]  M. Millan.  Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. , 2006, Pharmacology & therapeutics.

[36]  P. Zwanzger,et al.  Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients , 2006, Psychopharmacology.

[37]  Marian Joëls,et al.  Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  D. Souza,et al.  Ontogenetic profile of glutamate uptake in brain structures slices from rats: sensitivity to guanosine , 2004, Mechanisms of Ageing and Development.

[39]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[40]  P. Skolnick,et al.  Glutamate and Depression , 2003 .

[41]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[42]  M. Hascöet,et al.  The mouse light/dark box test. , 2003, European journal of pharmacology.

[43]  P. Skolnick,et al.  Glutamate and depression: clinical and preclinical studies. , 2003, Annals of the New York Academy of Sciences.

[44]  Á. Hermida-Ameijeiras,et al.  Inhibition of brain monoamine oxidase activity by the generation of hydroxyl radicals: potential implications in relation to oxidative stress. , 2001, Life sciences.

[45]  John H Krystal,et al.  Antidepressant effects of ketamine in depressed patients , 2000, Biological Psychiatry.

[46]  D. Stein,et al.  Pharmacotherapy for posttraumatic stress disorder. , 2000, The Cochrane database of systematic reviews.

[47]  R. Leal,et al.  Synaptosomal glutamate release induced by the fraction Bc2 from the venom of the sea anemone Bunodosoma caissarum. , 1999, Neuroreport.

[48]  M. Joëls,et al.  Brain corticosteroid receptor balance in health and disease. , 1998, Endocrine reviews.

[49]  B. Harvey.  The neurobiology and pharmacology of depression. A comparative overview of serotonin selective antidepressants. , 1997, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[50]  B. Moghaddam,et al.  Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam , 1997, Neuroscience.

[51]  B. Yamamoto,et al.  Effect of Acute Stress on Hippocampal Glutamate Levels and Spectrin Proteolysis in Young and Aged Rats , 1995, Journal of neurochemistry.

[52]  S. Checkley,et al.  Treatment of major depression with metyrapone and hydrocortisone. , 1995, Journal of affective disorders.

[53]  F. Antoni.  Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of Age , 1993, Frontiers in Neuroendocrinology.

[54]  Y. Nimura,et al.  3-(p-hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays. , 1984, Analytical biochemistry.

[55]  R. Porsolt,et al.  Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. , 1979, European journal of pharmacology.

[56]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[57]  M. Krajl.  A rapid microfluorimetric determination of monoamine oxidase. , 1965, Biochemical pharmacology.

[58]  V. P. Whittaker,et al.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. , 1962, Journal of anatomy.